GPX4 and ovarian cancer: ADT and Enz-induced sensitivity to GPX4 inhibition of PCa cells was reminiscent of lapatinib- and vemurafenib-induced drug tolerance and emergence of “persister cells” in melanoma, breast, lung, and ovarian cancer [9] and therapy-resistance-associated high-mesenchymal state cancer cells [78].